OVERVIEW

For Molecular Diagnostics and Genomics Companies
Choose the lab that can act immediately to help validate your product or idea.

US LABS knows that molecular diagnostics and genomics companies must carefully control their research and development costs. We also understand the first mover advantage, and we know how to support that effort.

Calling on a depth and breadth of services rarely available from other laboratories, we can conduct clinical trials that are efficient, and help validate products. Early validation can help our clients build market awareness and simultaneously drive additional interest among savvy investors in molecular diagnostics and genomics companies.

US LABS is technology agnostic, applying the right tools to each project. We’re sensitive to corporate timetables.